Sign Out
Atectura Breezhaler Inhalation Powder Hard Capsules 150 mcg/80 mcg: Transparent (uncoloured) capsules containing a white powder, with the product code "IM150-80" printed in blue above one blue bar on the body and with the product logo printed in blue and surrounded by two blue bars on the cap.
Each capsule contains 150 mcg of indacaterol (as acetate) and 80 mcg of mometasone furoate.
Each delivered dose (the dose that leaves the mouthpiece of the inhaler) contains 125 mcg of indacaterol (as acetate) and 62.5 mcg of mometasone furoate.
Atectura Breezhaler Inhalation Powder Hard Capsules 150 mcg/160 mcg: Transparent (uncoloured) capsules containing a white powder, with the product code "IM150-160" printed in grey on the body and with the product logo printed in grey on the cap.
Each capsule contains 150 mcg of indacaterol (as acetate) and 160 mcg of mometasone furoate.
Each delivered dose (the dose that leaves the mouthpiece of the inhaler) contains 125 mcg of indacaterol (as acetate) and 127.5 mcg of mometasone furoate.
Atectura Breezhaler Inhalation Powder Hard Capsules 150 mcg/320 mcg: Transparent (uncoloured) capsules containing a white powder, with the product code "IM150-320" printed in black above two black bars on the body and with the product logo printed in black and surrounded by two black bars on the cap.
Each capsule contains 150 mcg of indacaterol (as acetate) and 320 mcg of mometasone furoate.
Each delivered dose (the dose that leaves the mouthpiece of the inhaler) contains 125 mcg of indacaterol (as acetate) and 260 mcg of mometasone furoate.
Excipient(s) with known effect: Each capsule contains approximately 25 mg of lactose monohydrate.
Excipients/Inactive Ingredients: Capsule content: Lactose monohydrate.
Capsule shell: Gelatin, Printing ink.
Continue with Google